Nektar Therapeutics (CA) (NKTR) Reports Financial Results For The First Quarter Of 2014
5/8/2014 6:40:15 AM
SAN FRANCISCO, May 7, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported its financial results for the first quarter ended March 31, 2014.
Cash and investments in marketable securities at March 31, 2014 were $309.1 million as compared to $262.0 million at December 31, 2013. Our cash and investments in marketable securities balance at March 31, 2014 includes net proceeds of approximately $117 million from the issuance and sale of 9,775,000 shares of our common stock in a public offering in January 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by